Lataa...
OptMAVEn-2.0: De novo Design of Variable Antibody Regions against Targeted Antigen Epitopes
Monoclonal antibodies are becoming increasingly important therapeutic agents for the treatment of cancers, infectious diseases, and autoimmune disorders. However, laboratory-based methods of developing therapeutic monoclonal antibodies (e.g., immunized mice, hybridomas, and phage display) are time-c...
Tallennettuna:
| Julkaisussa: | Antibodies (Basel) |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
MDPI
2018
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6640672/ https://ncbi.nlm.nih.gov/pubmed/31544875 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/antib7030023 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|